e-DOL: E-health Tool for Management of Chronic Pain Patients.

Sponsor
University Hospital, Clermont-Ferrand (Other)
Overall Status
Completed
CT.gov ID
NCT03931694
Collaborator
Institut ANALGESIA (Other)
113
13
15.9
8.7
0.5

Study Details

Study Description

Brief Summary

Chronic pain affects approximately 20% of adults, 50% of the elderly population and over 1.5 billion people worldwide. Societal and economic issues are also crucial, as 60% of people with pain are less able or unable to work and 20% say they have lost their jobs because of pain. The overall cost of chronic pain is estimated at around 300 billion euros in the EU. Unfortunately, current treatments for chronic pain have limited effectiveness. Pain clinics, which support the most complex and refractory cases of chronic pain, as well as general practitioners and patients expect improvements, both in terms of therapeutic efficacy and organization of care.

In order to allow the characterization and a personalized follow-up of chronic pain patients, Investigator has created e-DOL, a smartphone application for patients and a web platform for physicians. The purpose of this study is to evaluate the feasibility and clinical interest of an e-Health smartphone application for the characterization and follow-up of chronic pain patients..

Condition or Disease Intervention/Treatment Phase
  • Device: e-DOL

Detailed Description

This first clinical study will assess the acceptability of the tool both by caregivers at the 13 pain clinics and by a panel of 300 patients followed for 6 months. Based on the results of the study (end 2019), investigator will improve the tool in a version 2.0, which will then be evaluated in a large impact study, measuring the intrinsic therapeutic effect of eDOL.

Study Design

Study Type:
Observational
Actual Enrollment :
113 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Evaluation of the Feasibility of an E-health Tool in the Follow-up and Characterization of Chronic Pain Patients.
Actual Study Start Date :
Feb 6, 2019
Actual Primary Completion Date :
Jun 4, 2020
Actual Study Completion Date :
Jun 4, 2020

Arms and Interventions

Arm Intervention/Treatment
All patients with chronic pain follow in pain clinic

Device: e-DOL
e-health program (smartphone and web platform)

Outcome Measures

Primary Outcome Measures

  1. Feasibility of the e-health tool [Once, up to 12 months]

    Feasibility evaluated by analysis of user acceptability (custom questionnaire: ease of use, utility...)

  2. Feasibility of the e-health tool [Once, up to 12 months]

    Feasibility evaluated by analysis of Number of data completed / missing (% of responses)

  3. Feasibility of the e-health tool [Once, up to 12 months]

    Feasibility evaluated by analysis of Participation of investigator centres (inclusion rate)

Secondary Outcome Measures

  1. Typology of patient responses [Weekly, up to 6 months]

    Temporal evolution of the pain intensity using 0-10 VAS

  2. Typology of patient responses [Up to 6 months]

    Temporal evolution of the anxiety using 0-10 VAS

  3. Typology of patient responses [Up to 6 months]

    Temporal evolution of the sleep quality using 0-10 VAS

  4. Typology of patient responses [Up to 6 months]

    Temporal evolution of the mood using 0-10 VAS

  5. Typology of patient responses [Up to 6 months]

    Temporal evolution of the body comfort using 0-10 VAS

  6. Typology of patient responses [Up to 6 months]

    temporal evolution of the chronic pain symptoms and related-comorbidities by Brief Pain Inventory questionnaire

  7. Typology of patient responses [Up to 6 months]

    temporal evolution of the chronic pain symptoms and related-comorbidities by Pain Beliefs and Perceptions Inventory questionnaire

  8. Typology of patient responses [Up to 6 months]

    temporal evolution of the chronic pain symptoms and related-comorbidities by Medical Outcomes Study-Sleep Scale questionnaire

  9. Typology of patient responses [Up to 6 months]

    temporal evolution of the chronic pain symptoms and related-comorbidities by Tampa Scale of Kinesiophobia questionnaire

  10. Typology of patient responses [Up to 6 months]

    temporal evolution of the chronic pain symptoms and related-comorbidities by Pain Catastrophizing Scale questionnaire

  11. Typology of patient responses [Up to 6 months]

    temporal evolution of the chronic pain symptoms and related-comorbidities by EQ-5D questionnaire

  12. Typology of patient responses [Up to 6 months]

    temporal evolution of the chronic pain symptoms and related-comorbidities by ,Hospital Anxiety Depression Scale questionnaire

  13. impact of the eHealth tool [Once, Up to 12 months.]

    evaluation of the impact of the eHealth tool on current practices (clinician's opinion)

  14. impact of the eHealth tool [Once, up 12 months.]

    evaluation of the impact of the eHealth tool on quality of life (patient's opinion)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • All patients with chronic pain

  • patients with and regular users of a smartphone

  • Non-opposition to participation in the study

Exclusion Criteria:
  • Patient unable to understand or answer questionnaires

Contacts and Locations

Locations

Site City State Country Postal Code
1 Chu Amiens Amiens France
2 Ch Bayeux Bayeux France
3 Chu Clermont-Ferrand Clermont-Ferrand France 63003
4 Chu Grenoble Grenoble France
5 Chu Limoges Limoges France
6 Hospices Civils de Lyon Lyon France
7 Chu Nimes Nîmes France
8 AP-HP Ambroise Paré Paris France
9 Ap-Hp Cochin Paris France
10 Ap-Hp Lariboisiere Paris France
11 Chu Rouen Rouen France
12 Chu Toulouse Toulouse France
13 Ch Voiron Voiron France

Sponsors and Collaborators

  • University Hospital, Clermont-Ferrand
  • Institut ANALGESIA

Investigators

  • Principal Investigator: Noémie DELAGE, University Hospital, Clermont-Ferrand

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Clermont-Ferrand
ClinicalTrials.gov Identifier:
NCT03931694
Other Study ID Numbers:
  • CHU-425
  • 2018-A01790-5546
First Posted:
Apr 30, 2019
Last Update Posted:
Sep 21, 2020
Last Verified:
Sep 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Clermont-Ferrand
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 21, 2020